Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review

Investigator Perspectives on Available Resear...

Research To PracticeResearch To Practice

‏التالي

PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer — An Interview with Dr Wassim Abida

Dr Wassim Abida from Memorial Sloan Kettering Cancer Center in New York, New York, discusses the role of PARP inhibitors in the management of hormone-sensitive and castration-resistant metastatic prostate cancer.CME information and select publications here. 

 . 51 دقيقة و55 ثانية
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances

Dr Andrew J Armstrong from the Duke Cancer Institute in Durham, North Carolina, and Dr Scott T Tagawa from Weill Cornell Medicine Meyer Cancer Center in New York, New York, discuss the selection and sequencing of therapy for patients with prostate cancer and summarize major advan ...  عرض المزيد

 . 58 دقيقة و21 ثانية

‏حلقات موصى بها

18F-PSMA-1007 PET/CT - Sponsored by Mayo Clinic
Radiology Podcast | RSNA

Dr. Ashwin Singh Parihar discusses the role of multiparametric MRI and 18F-PSMA-1007 PET/CT for the detection of clinically significant prostate cancer with Dr. Bastiaan Privé. This episode is sponsored by Mayo Clinic. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detectio ...  عرض المزيد

 . 18 دقيقة و6 ثانية
Professor Joël Guigay on clinical trials of older patients with head and neck cancer
The Lancet Healthy Longevity in conversation with

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles: https://www.thelancet.com/ ...  عرض المزيد

 . 34 دقيقة و38 ثانية
AUANewsWorthy Webinar: An Integrated Biomarker and MRI Risk Assessment Approach to Prostate Cancer Diagnosis
AUANews Inside Tract

Prostate cancer diagnostic guidelines aim to minimize over-diagnosis of clinically insignificant prostate cancer (Gleason6/GG1). The clinical question before us is how do we enable the best balance, helping to increase compliance with the biopsy recommendation for patients at hig ...  عرض المزيد

 . 51 دقيقة و37 ثانية
A Reassessment of Prostate Cancer Treatment (Live from the 2024 ASCO Annual Meeting)
Symptomatic: A Medical Mystery Podcast

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Join Lauren Bright Pacheco at the 2024 ASCO Annual Meeting in Chicago, as she investigates the advancements in prostate cancer care.  Dr. Mohammad Atiq shares ways innovative treatments are paving the ...  عرض المزيد

 . 41 دقيقة و41 ثانية